Abstract <p>In this work, the molecular hybridization approach was employed to design a series of benzooxepine linked to 1,2,3-triazolyl chalcone structures, and the prepared molecules were synthesized using a click chemistry protocol. Several spectral approaches, including infrared, <sup>1</sup>H NMR, <sup>13</sup>C NMR, IR and HRMS spectrometric analysis, were used to determine the product structures. Three of the investigated compounds <i>p</i>-fluorophenyl, and <i>o</i>-nitrophenyl substituted chalcones shown remarkable antibacterial susceptibilities against the tested strain of <i>S. aureus</i>, with MICs (minimum inhibitory concentrations) ranging from 4.26±0.52 to 6.19±0.11 μg/mL. When compared to clotrimazole (MIC = 6.10±0.81 μg/mL), the prepared scaffolds showed better antifungal activity against <i>C. albicans</i>, with MIC values ranging from 4.45±0.14 to 38.79±1.32 μg/mL. Furthermore, a small number of derivatives with MIC ranges of 3.01 to 5.12 μM showed comparable antitubercular activity against the <i>H</i><sub>37</sub><i>Rv</i> strain. Docking experiments verified one of the ligand abilities to build a stable compound on the CYP51 active site from <i>M. TB</i> (PDB code: 1EA1). The chalcone-1,2,3-triazole hybrids molecular properties, bioactivity scores, toxicity assessment, and ADME were also evaluated. Furthermore, In-silico ADME, molecular docking revealed that the active compounds have substantial potential as candidates for the development of novel antitubercular medicines.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A New 1,2,3-Triazole-Based Benzooxepines: Design, Synthesis, and In Silico Docking, ADME-T and Antimicrobial Evaluation

  • Sateesh Kuna,
  • Madhusudhan Patlola,
  • Srinu Bhoomandla,
  • Sreedhar Pandiri,
  • Premalatha Akarapu,
  • Tejeswara Rao Allaka

摘要

Abstract

In this work, the molecular hybridization approach was employed to design a series of benzooxepine linked to 1,2,3-triazolyl chalcone structures, and the prepared molecules were synthesized using a click chemistry protocol. Several spectral approaches, including infrared, 1H NMR, 13C NMR, IR and HRMS spectrometric analysis, were used to determine the product structures. Three of the investigated compounds p-fluorophenyl, and o-nitrophenyl substituted chalcones shown remarkable antibacterial susceptibilities against the tested strain of S. aureus, with MICs (minimum inhibitory concentrations) ranging from 4.26±0.52 to 6.19±0.11 μg/mL. When compared to clotrimazole (MIC = 6.10±0.81 μg/mL), the prepared scaffolds showed better antifungal activity against C. albicans, with MIC values ranging from 4.45±0.14 to 38.79±1.32 μg/mL. Furthermore, a small number of derivatives with MIC ranges of 3.01 to 5.12 μM showed comparable antitubercular activity against the H37Rv strain. Docking experiments verified one of the ligand abilities to build a stable compound on the CYP51 active site from M. TB (PDB code: 1EA1). The chalcone-1,2,3-triazole hybrids molecular properties, bioactivity scores, toxicity assessment, and ADME were also evaluated. Furthermore, In-silico ADME, molecular docking revealed that the active compounds have substantial potential as candidates for the development of novel antitubercular medicines.